Genpharmasec Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 329838,
    "name": "Genpharmasec",
    "stock_name": "Genpharmasec",
    "full_name": "Genpharmasec Ltd",
    "name_url": "stocks-analysis/genpharmasec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.17",
    "chg": 0.03,
    "chgp": "2.63%",
    "dir": 1,
    "prev_price": "1.14",
    "mcapval": "65.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531592,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE861N01036",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "32.56 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/genpharmasec-329838-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genpharmasec Stock Falls to 52-Week Low of Rs.1.41 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-stock-falls-to-52-week-low-of-rs141-amidst-weak-performance-3744205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Genpharmasec_priceRelatedfactors_3744205.png",
        "date": "2025-12-03 11:42:08",
        "description": "Genpharmasec has reached a new 52-week low of Rs.1.41, marking a significant decline in its share price amid a challenging market environment and subdued financial performance over the past year."
      },
      {
        "title": "Why is Genpharmasec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-genpharmasec-fallingrising-3698496",
        "imagepath": "",
        "date": "2025-11-13 21:42:52",
        "description": "As of 13-Nov, Genpharmasec Ltd's stock price is currently at 1.55, reflecting an increase of 0.06, or 4.03%. The stock has been gaining for the last two days, with a total return of 7.64% during this period. Despite this recent uptick, the stock has shown a significant decline over longer periods, with a year-to-date drop of 49.84% and a one-year decrease of 45.99%. The stock's performance today has outpaced its sector by 4.75%, although it is trading higher than its 5-day moving average but lower than its 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 28.06% compared to the 5-day average, indicating reduced trading activity.\n\nBroader Market Context: In the short term, Genpharmasec's stock has outperformed the benchmark Sensex, which has increased by 1.40% over the past week, while Genpharmasec h..."
      },
      {
        "title": "Why is Genpharmasec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-genpharmasec-fallingrising-3690705",
        "imagepath": "",
        "date": "2025-11-11 21:34:01",
        "description": "As of 11-Nov, Genpharmasec Ltd's stock price is currently at Rs. 1.44, reflecting a decrease of Rs. 0.06 or 4.0%. The stock has recently hit a new 52-week low of Rs. 1.42, indicating significant downward pressure. It has underperformed its sector by 4.48% today and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, investor participation has declined, with delivery volume dropping by 26.77% compared to the 5-day average. Over the past week, the stock has seen a decline of 8.28%, and its year-to-date performance shows a staggering drop of 53.40%, further highlighting its struggles in the market.\n\nIn the broader market context, the Sensex has shown a positive return of 0.49% over the past week, contrasting sharply with Genpharmasec's negative performance. While the benchmark has gained 1.66% over the past month, Genpharmasec has experien..."
      },
      {
        "title": "Genpharmasec Stock Plummets to New 52-Week Low of Rs. 1.47",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-stock-plummets-to-new-52-week-low-of-rs-147-3689988",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Genpharmasec_priceRelatedfactors_3689988.png",
        "date": "2025-11-11 14:13:02",
        "description": "Genpharmasec, a microcap in the Trading & Distributors sector, has reached a new 52-week low, reflecting a significant decline over the past year. Despite reporting positive quarterly results, the company's long-term fundamentals remain weak, with challenges in debt servicing and consistent underperformance compared to the broader market."
      },
      {
        "title": "Genpharmasec Q2 FY26: Profit Surge Masks Deteriorating Fundamentals",
        "link": "https://www.marketsmojo.com/news/result-analysis/genpharmasec-q2-fy26-profit-surge-masks-deteriorating-fundamentals-3682298",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Genpharmasec_quaterlyResult_3682298.png",
        "date": "2025-11-08 11:46:55",
        "description": "Genpharmasec Ltd., a micro-cap trading and distribution company, reported a net profit of ₹1.22 crores for Q2 FY26, marking a dramatic 269.70% year-on-year surge from ₹0.33 crores in Q2 FY25. However, this headline figure conceals a troubling sequential decline, with profits plunging 551.85% quarter-on-quarter from a loss of ₹0.27 crores in Q1 FY26. The company's shares, currently trading at ₹1.52, have collapsed 50.97% over the past year, reflecting deep-seated investor concerns about the sustainability of its business model and deteriorating financial health."
      },
      {
        "title": "Genpharmasec Hits New 52-Week Low at Rs. 1.5 Amid Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-hits-new-52-week-low-at-rs-15-amid-market-decline-3679453",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Genpharmasec_priceRelatedfactors_3679453.png",
        "date": "2025-11-07 10:15:09",
        "description": "Genpharmasec, a microcap in the Trading & Distributors sector, has reached a new 52-week low, reflecting a 50% decline over the past year. Despite a recent performance improvement, the stock struggles below key moving averages and faces challenges with long-term financial strength and debt servicing capabilities, despite a notable increase in net sales."
      },
      {
        "title": "How has been the historical performance of Genpharmasec?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-genpharmasec-3676962",
        "imagepath": "",
        "date": "2025-11-06 22:44:42",
        "description": "Answer:\nThe historical performance of Genpharmasec shows a mixed trend over the past three years, with notable fluctuations in revenue and profit metrics.\n\nBreakdown:\nGenpharmasec's net sales have increased from 25.52 Cr in Mar'23 to 30.41 Cr in Mar'24, and further to 33.72 Cr in Mar'25, indicating a steady growth in total operating income. The total expenditure has also risen, from 25.26 Cr in Mar'23 to 30.36 Cr in Mar'24, and 33.66 Cr in Mar'25, reflecting increased costs in purchases and employee expenses. Operating profit, however, has shown variability, with a peak of 0.36 Cr in Mar'23, dropping to 0.05 Cr in Mar'24, and slightly recovering to 0.06 Cr in Mar'25. Profit before tax improved significantly from 0.28 Cr in Mar'23 to 1.88 Cr in Mar'25, while profit after tax showed a recovery from a loss of 0.17 Cr in Mar'24 to a profit of 1.23 Cr in Mar'25. The company's total assets have increased from 19...."
      },
      {
        "title": "Why is Genpharmasec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-genpharmasec-fallingrising-3676590",
        "imagepath": "",
        "date": "2025-11-06 21:29:36",
        "description": "As of 06-Nov, Genpharmasec Ltd's stock price is currently at Rs. 1.52, reflecting a decrease of Rs. 0.05 or 3.18%. The stock has been underperforming significantly, having hit a new 52-week low of Rs. 1.51 today. Over the past five days, it has experienced a consecutive decline, resulting in a total drop of 14.61%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased by 11.19% compared to the 5-day average, suggesting a decline in investor participation. There are no positive factors available to counterbalance these negative indicators.\n\nBroader market context shows that Genpharmasec's performance has been notably poor compared to the benchmark index, Sensex. Over the past week, the stock has fallen by 8.98%, while the Sensex has only declined by 1.30%. In the longer term, the stock's yea..."
      },
      {
        "title": "Genpharmasec Stock Plummets to New 52-Week Low at Rs. 1.54",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-stock-plummets-to-new-52-week-low-at-rs-154-3675445",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Genpharmasec_priceRelatedfactors_3675445.png",
        "date": "2025-11-06 10:46:16",
        "description": "Genpharmasec has reached a new 52-week low, marking a significant downturn after a five-day decline. The stock is trading below multiple moving averages and has underperformed over the past year. Despite a substantial increase in operating profit, long-term fundamentals and debt servicing capabilities raise concerns."
      }
    ],
    "total": 5399,
    "sid": "329838",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/genpharmasec-329838"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday 09Th February 2026.",
      "datetime": "02-Feb-2026",
      "details": "Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter ended 31st December 2025; 2. To consider any other business Matter with the permission of a Chairman.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositories & Participants) Regulation 2018 for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "Intimation Regarding Closure of Trading Window.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Apr 19",
          "dt": "2019-04-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:1</strong> rights issue, ex-date: 09 Jan 24",
          "dt": "2024-01-09",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Genpharmasec Stock Falls to 52-Week Low of Rs.1.41 Amidst Prolonged Downtrend

2025-12-03 11:42:08

Genpharmasec has reached a new 52-week low of Rs.1.41, marking a significant decline in its share price amid a challenging market environment and subdued financial performance over the past year.

Why is Genpharmasec falling/rising?

2025-11-13 21:42:52

As of 13-Nov, Genpharmasec Ltd's stock price is currently at 1.55, reflecting an increase of 0.06, or 4.03%. The stock has been gaining for the last two days, with a total return of 7.64% during this period. Despite this recent uptick, the stock has shown a significant decline over longer periods, with a year-to-date drop of 49.84% and a one-year decrease of 45.99%. The stock's performance today has outpaced its sector by 4.75%, although it is trading higher than its 5-day moving average but lower than its 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 28.06% compared to the 5-day average, indicating reduced trading activity. Broader Market Context: In the short term, Genpharmasec's stock has outperformed the benchmark Sensex, which has increased by 1.40% over the past week, while Genpharmasec h...

Why is Genpharmasec falling/rising?

2025-11-11 21:34:01

As of 11-Nov, Genpharmasec Ltd's stock price is currently at Rs. 1.44, reflecting a decrease of Rs. 0.06 or 4.0%. The stock has recently hit a new 52-week low of Rs. 1.42, indicating significant downward pressure. It has underperformed its sector by 4.48% today and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, investor participation has declined, with delivery volume dropping by 26.77% compared to the 5-day average. Over the past week, the stock has seen a decline of 8.28%, and its year-to-date performance shows a staggering drop of 53.40%, further highlighting its struggles in the market. In the broader market context, the Sensex has shown a positive return of 0.49% over the past week, contrasting sharply with Genpharmasec's negative performance. While the benchmark has gained 1.66% over the past month, Genpharmasec has experien...

Genpharmasec Stock Plummets to New 52-Week Low of Rs. 1.47

2025-11-11 14:13:02

Genpharmasec, a microcap in the Trading & Distributors sector, has reached a new 52-week low, reflecting a significant decline over the past year. Despite reporting positive quarterly results, the company's long-term fundamentals remain weak, with challenges in debt servicing and consistent underperformance compared to the broader market.

Genpharmasec Q2 FY26: Profit Surge Masks Deteriorating Fundamentals

2025-11-08 11:46:55

Genpharmasec Ltd., a micro-cap trading and distribution company, reported a net profit of ₹1.22 crores for Q2 FY26, marking a dramatic 269.70% year-on-year surge from ₹0.33 crores in Q2 FY25. However, this headline figure conceals a troubling sequential decline, with profits plunging 551.85% quarter-on-quarter from a loss of ₹0.27 crores in Q1 FY26. The company's shares, currently trading at ₹1.52, have collapsed 50.97% over the past year, reflecting deep-seated investor concerns about the sustainability of its business model and deteriorating financial health.

Genpharmasec Hits New 52-Week Low at Rs. 1.5 Amid Market Decline

2025-11-07 10:15:09

Genpharmasec, a microcap in the Trading & Distributors sector, has reached a new 52-week low, reflecting a 50% decline over the past year. Despite a recent performance improvement, the stock struggles below key moving averages and faces challenges with long-term financial strength and debt servicing capabilities, despite a notable increase in net sales.

How has been the historical performance of Genpharmasec?

2025-11-06 22:44:42

Answer: The historical performance of Genpharmasec shows a mixed trend over the past three years, with notable fluctuations in revenue and profit metrics. Breakdown: Genpharmasec's net sales have increased from 25.52 Cr in Mar'23 to 30.41 Cr in Mar'24, and further to 33.72 Cr in Mar'25, indicating a steady growth in total operating income. The total expenditure has also risen, from 25.26 Cr in Mar'23 to 30.36 Cr in Mar'24, and 33.66 Cr in Mar'25, reflecting increased costs in purchases and employee expenses. Operating profit, however, has shown variability, with a peak of 0.36 Cr in Mar'23, dropping to 0.05 Cr in Mar'24, and slightly recovering to 0.06 Cr in Mar'25. Profit before tax improved significantly from 0.28 Cr in Mar'23 to 1.88 Cr in Mar'25, while profit after tax showed a recovery from a loss of 0.17 Cr in Mar'24 to a profit of 1.23 Cr in Mar'25. The company's total assets have increased from 19....

Why is Genpharmasec falling/rising?

2025-11-06 21:29:36

As of 06-Nov, Genpharmasec Ltd's stock price is currently at Rs. 1.52, reflecting a decrease of Rs. 0.05 or 3.18%. The stock has been underperforming significantly, having hit a new 52-week low of Rs. 1.51 today. Over the past five days, it has experienced a consecutive decline, resulting in a total drop of 14.61%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased by 11.19% compared to the 5-day average, suggesting a decline in investor participation. There are no positive factors available to counterbalance these negative indicators. Broader market context shows that Genpharmasec's performance has been notably poor compared to the benchmark index, Sensex. Over the past week, the stock has fallen by 8.98%, while the Sensex has only declined by 1.30%. In the longer term, the stock's yea...

Genpharmasec Stock Plummets to New 52-Week Low at Rs. 1.54

2025-11-06 10:46:16

Genpharmasec has reached a new 52-week low, marking a significant downturn after a five-day decline. The stock is trading below multiple moving averages and has underperformed over the past year. Despite a substantial increase in operating profit, long-term fundamentals and debt servicing capabilities raise concerns.

View All News